Evidence map›Paper›PMID 20636339›Full record

ArticleImmunology2010

A critical function of toll-like receptor-3 in the induction of anti-human immunodeficiency virus activities in macrophages.

Yu Zhou, Xu Wang, Manqing Liu, Quan Hu, Li Song, Li Ye, Dunjin Zhou, Wenzhe Ho

Open access · greenAbstract read
In one paragraph

Article in Immunology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 109 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Toll-like Receptor Mediation in SARS-CoV-2: A Therapeutic Approach.International journal of molecular sciences · 2022
    Review
  18. Article
  19. Review
  20. Article

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Yu ZhouDivision of Virology, Wuhan Centres for Disease Control and Prevention, Wuhan, China.
Xu Wang
Manqing Liu
Quan Hu
Li Song
Li Ye
Dunjin Zhou
Wenzhe Ho
Temple University · USWuhan Center for Disease Control and Prevention · CN

Funding

Drug Abuse, Sustance P and HIVR01DA012815 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI HO, WENZHE · 2000 to 2013
$4.5M
Opioids, HIV/HCV and Host Cell Innate ImmunityR01DA022177 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI HO, WENZHE · 2007 to 2017
$2.9M
Opioids, LPS and HIVR01DA027550 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI HO, WENZHE · 2010 to 2014
$1.4M
NIDA NIH HHS R01 DA012815NIDA NIH HHS R01 DA022177NIDA NIH HHS R01 DA027550PHS HHS NIDA012815PHS HHS NIDA022177PHS HHS NIDA025477PHS HHS NIDA027550
6 · The paper itself

Abstract

Toll-like receptor-3 (TLR-3) recognizes double-stranded RNA and induces multiple intracellular events responsible for innate anti-viral immunity against a number of viral infections. Activation of TLR-3 inhibits human immunodeficiency virus (HIV) replication, but the mechanism(s) underlying the action of TLR-3 activation on HIV are largely unknown. Here we demonstrate that treatment of monocyte-derived macrophages with poly I:C, a synthetic ligand for TLR-3, significantly inhibited HIV infection and replication. Investigation of the mechanisms showed that TLR-3 activation resulted in the induction of type I interferon inducible antiviral factors, including APOBEC3G and tetherin, the newly identified anti-HIV cellular proteins. In addition, poly I:C-treated macrophages expressed increased levels of CC chemokines, the ligands for CCR5. Furthermore, TLR-3 activation in macrophages induced the expression of cellular microRNAs (miRNA-28, -125b, -150, -223 and -382), the newly identified intracellular HIV restriction factors. These findings indicate that TLR-3-mediated induction of multiple anti-HIV factors should be beneficial for the treatment of HIV disease where innate immune responses are compromised by the virus.

Indexed as

Antigens, CDAntiviral AgentsCytidine DeaminaseHIV-1Membrane GlycoproteinsAPOBEC-3G DeaminaseBone Marrow Stromal Antigen 2Chemokines, CCGPI-Linked ProteinsHIV InfectionsHumansImmunity, InnateInterferon Type IMacrophagesMicroRNAsPoly I-CAntigens, CDAntiviral AgentsAPOBEC-3G DeaminaseAPOBEC3G protein, humanBone Marrow Stromal Antigen 2BST2 protein, humanChemokines, CCCytidine DeaminaseGPI-Linked ProteinsInterferon Type IMembrane GlycoproteinsMicroRNAsPoly I-CRNA, Double-StrandedTLR3 protein, humanToll-Like Receptor 3

Identifiers

PMID20636339
PMCPMC2966756
OpenAlexW1521072910

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.